Literature DB >> 12031080

Matrix metalloproteinases in tumor invasion: role for cell migration.

Kazuki Nabeshima1, Teruhiko Inoue, Yoshiya Shimao, Tetsuro Sameshima.   

Abstract

Matrix metalloproteinases (MMP) play a role in a wide range of tumorigenesis, including early carcinogenesis events, tumor growth and tumor invasion and metastasis. Given that the ability of tumor cells to infiltrate and disseminate widely is what makes the tumors malignant, a role of MMP in cell migration during this invasive and metastatic process is important. There are two types of cancer cell migration: single cell locomotion and cohort migration (cell movement en mass keeping cell-cell contact, which is frequently seen in better differentiated carcinomas). Cell surface localization and activation of MMP is essential for cells to migrate, through rearrangement of extracellular matrix (ECM) to suit cell migration. Certain MMP, such as gelatinases and membrane -type 1 MMP, have special mechanisms to localize at leading edges in both types of cell migration. Moreover, in cohort migration, expression of these MMP is regulated via cell-cell contact within migrating cell sheets and confined to the foremost pathfinder cells of the migrating cell sheets. New roles of cell surface MMP, such as cleavage of cell surface receptors or cofactors involved in cell-ECM interactions during cell migration, are also discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031080     DOI: 10.1046/j.1440-1827.2002.01343.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  116 in total

1.  Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics.

Authors:  M P Lutolf; J L Lauer-Fields; H G Schmoekel; A T Metters; F E Weber; G B Fields; J A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-09       Impact factor: 11.205

2.  Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model.

Authors:  Odete Mendes; Hun-Taek Kim; George Stoica
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 3.  Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes.

Authors:  Arthur Winer; Sylvia Adams; Paolo Mignatti
Journal:  Mol Cancer Ther       Date:  2018-05-07       Impact factor: 6.261

4.  Glioma expansion in collagen I matrices: analyzing collagen concentration-dependent growth and motility patterns.

Authors:  L J Kaufman; C P Brangwynne; K E Kasza; E Filippidi; V D Gordon; T S Deisboeck; D A Weitz
Journal:  Biophys J       Date:  2005-04-22       Impact factor: 4.033

Review 5.  N-Methyl-N-nitrosourea as a mammary carcinogenic agent.

Authors:  Ana I Faustino-Rocha; Rita Ferreira; Paula A Oliveira; Adelina Gama; Mário Ginja
Journal:  Tumour Biol       Date:  2015-09-19

Review 6.  Ovarian cancer: involvement of the matrix metalloproteinases.

Authors:  Linah Al-Alem; Thomas E Curry
Journal:  Reproduction       Date:  2015-04-27       Impact factor: 3.906

7.  Artemisinin reduces human melanoma cell migration by down-regulating alpha V beta 3 integrin and reducing metalloproteinase 2 production.

Authors:  Elisabetta Buommino; Adone Baroni; Nunzia Canozo; Marcella Petrazzuolo; Rosario Nicoletti; Antonio Vozza; Maria Antonietta Tufano
Journal:  Invest New Drugs       Date:  2008-10-28       Impact factor: 3.850

8.  Mutational analysis of Drosophila basigin function in the visual system.

Authors:  Michelle Munro; Yazan Akkam; Kathryn D Curtin
Journal:  Gene       Date:  2009-09-25       Impact factor: 3.688

Review 9.  Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development.

Authors:  Lidiya S Orlichenko; Derek C Radisky
Journal:  Clin Exp Metastasis       Date:  2008-02-20       Impact factor: 5.150

Review 10.  The receptor for advanced glycation end products (RAGE) and the lung.

Authors:  Stephen T Buckley; Carsten Ehrhardt
Journal:  J Biomed Biotechnol       Date:  2010-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.